Standartization of broth microdilution method for Mycobacterium tuberculosis

Leite, Clarice Queico Fujimura; Beretta, Ana Laura Remédio Zeni; Anno, Ivone Shizuko; Telles, Maria Alice da Silva.
Mem. Inst. Oswaldo Cruz ; 95(1): 127-9, Jan.-Feb. 2000. tab
Artículo en Inglés | LILACS | ID: lil-251325

Documentos relacionados

  1. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
  2. Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
  3. Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.
  4. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
  5. Protein Binding of First-Line Antituberculosis Drugs.
  6. [Clinical value of the MeltPro MTB assays in detection of drug-resistant tuberculosis in paraffin-embedded tissues].
  7. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
  8. Gene expression responses to anti-tuberculous drugs in a whole blood model.
  9. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
  10. The Rate of Drug-Resistant Tuberculosis in Korean Children and Adolescents Since 2007.